Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Fraunhofer USA Center for Molecular Biotechnology Begins Clinical Trial of New Malaria Vaccine Approach

01:00 EST 5 Feb 2014 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer’s plant-derived malaria t...

Other Sources for this Article

Fraunhofer USA Center for Molecular Biotechnology
Dale Ervin, 302-369-3034
dervin@fraunhofer-cmb.org

NEXT ARTICLE

More From BioPortfolio on "Fraunhofer USA Center for Molecular Biotechnology Begins Clinical Trial of New Malaria Vaccine Approach"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story